mRNA-based therapeutics–Advances and perspectives

In this review we discuss features of mRNA synthesis and modifications used to minimize immune response and prolong efficiency of the translation process in vivo . Considerable attention is given to the use of liposomes and nanoparticles containing lipids and polymers for the mRNA delivery. Finally...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemistry (Moscow) 2016-07, Vol.81 (7), p.709-722
Hauptverfasser: Sergeeva, O. V., Koteliansky, V. E., Zatsepin, T. S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 722
container_issue 7
container_start_page 709
container_title Biochemistry (Moscow)
container_volume 81
creator Sergeeva, O. V.
Koteliansky, V. E.
Zatsepin, T. S.
description In this review we discuss features of mRNA synthesis and modifications used to minimize immune response and prolong efficiency of the translation process in vivo . Considerable attention is given to the use of liposomes and nanoparticles containing lipids and polymers for the mRNA delivery. Finally we briefly discuss mRNAs which are currently in the clinical trials for cancer immunotherapy, vaccination against infectious diseases, and replacement therapy.
doi_str_mv 10.1134/S0006297916070075
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1808709597</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A528327556</galeid><sourcerecordid>A528327556</sourcerecordid><originalsourceid>FETCH-LOGICAL-c500t-821e635e111913deb06fae4529c2d86e16d6afd3aa1d261766fb43b63d2c0c303</originalsourceid><addsrcrecordid>eNqNkc1u1DAUhS1ExUynPAAbNBIbNple24kdL6OqUKSqlVpYW459UzLKH3YyEjvegTfkSXA0A7RAEfLCP-c7x_fqEvKCwoZSnp7eAoBgSioqQALI7AlZxmOecEjhKVnOcjLrC3IcwjZeGSj-jCyYTFMlqFwS3t5cFUlpArr1-BG9GXAaaxu-fflauJ3pLIa16dx6QB8GtGO9w3BCjirTBHx-2Ffkw5vz92cXyeX123dnxWViM4AxyRlFwTOklCrKHZYgKoNpxpRlLhdIhROmctwY6lgsRoiqTHkpuGMWLAe-Iq_3uYPvP00YRt3WwWLTmA77KWiaQy5BZUr-DypBqpSlEX31G7rtJ9_FRjTLqVSQsVz9i4pZnCtQwH5Rd6ZBXXdVP3pj5691EWM4k1kmIrX5CxWXw7a2fYdVHd8fGOjeYH0fgsdKD75ujf-sKeh58vqPyUfPy0PBU9mi--n4MeoIsD0QotTdob_X0aOp3wFvWLMr</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1803390902</pqid></control><display><type>article</type><title>mRNA-based therapeutics–Advances and perspectives</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Sergeeva, O. V. ; Koteliansky, V. E. ; Zatsepin, T. S.</creator><creatorcontrib>Sergeeva, O. V. ; Koteliansky, V. E. ; Zatsepin, T. S.</creatorcontrib><description>In this review we discuss features of mRNA synthesis and modifications used to minimize immune response and prolong efficiency of the translation process in vivo . Considerable attention is given to the use of liposomes and nanoparticles containing lipids and polymers for the mRNA delivery. Finally we briefly discuss mRNAs which are currently in the clinical trials for cancer immunotherapy, vaccination against infectious diseases, and replacement therapy.</description><identifier>ISSN: 0006-2979</identifier><identifier>EISSN: 1608-3040</identifier><identifier>DOI: 10.1134/S0006297916070075</identifier><identifier>PMID: 27449617</identifier><language>eng</language><publisher>Moscow: Pleiades Publishing</publisher><subject>Animals ; Biochemistry ; Biomedical and Life Sciences ; Biomedicine ; Bioorganic Chemistry ; Cancer immunotherapy ; Clinical trials ; Drug Carriers - chemistry ; Humans ; Immune response ; Immune system ; Immunity, Innate ; Immunotherapy ; Infectious diseases ; Life Sciences ; Lipids ; Liposomes - chemistry ; Microbiology ; Nanoparticles ; Nanoparticles - chemistry ; Neoplasms - immunology ; Neoplasms - therapy ; Polymers ; Review ; RNA, Messenger - chemistry ; RNA, Messenger - genetics ; RNA, Messenger - metabolism ; Transcription ; Vaccination ; Vaccines</subject><ispartof>Biochemistry (Moscow), 2016-07, Vol.81 (7), p.709-722</ispartof><rights>Pleiades Publishing, Ltd. 2016</rights><rights>COPYRIGHT 2016 Springer</rights><rights>Pleiades Publishing, Ltd. 2016.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c500t-821e635e111913deb06fae4529c2d86e16d6afd3aa1d261766fb43b63d2c0c303</citedby><cites>FETCH-LOGICAL-c500t-821e635e111913deb06fae4529c2d86e16d6afd3aa1d261766fb43b63d2c0c303</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1134/S0006297916070075$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1134/S0006297916070075$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27449617$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sergeeva, O. V.</creatorcontrib><creatorcontrib>Koteliansky, V. E.</creatorcontrib><creatorcontrib>Zatsepin, T. S.</creatorcontrib><title>mRNA-based therapeutics–Advances and perspectives</title><title>Biochemistry (Moscow)</title><addtitle>Biochemistry Moscow</addtitle><addtitle>Biochemistry (Mosc)</addtitle><description>In this review we discuss features of mRNA synthesis and modifications used to minimize immune response and prolong efficiency of the translation process in vivo . Considerable attention is given to the use of liposomes and nanoparticles containing lipids and polymers for the mRNA delivery. Finally we briefly discuss mRNAs which are currently in the clinical trials for cancer immunotherapy, vaccination against infectious diseases, and replacement therapy.</description><subject>Animals</subject><subject>Biochemistry</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Bioorganic Chemistry</subject><subject>Cancer immunotherapy</subject><subject>Clinical trials</subject><subject>Drug Carriers - chemistry</subject><subject>Humans</subject><subject>Immune response</subject><subject>Immune system</subject><subject>Immunity, Innate</subject><subject>Immunotherapy</subject><subject>Infectious diseases</subject><subject>Life Sciences</subject><subject>Lipids</subject><subject>Liposomes - chemistry</subject><subject>Microbiology</subject><subject>Nanoparticles</subject><subject>Nanoparticles - chemistry</subject><subject>Neoplasms - immunology</subject><subject>Neoplasms - therapy</subject><subject>Polymers</subject><subject>Review</subject><subject>RNA, Messenger - chemistry</subject><subject>RNA, Messenger - genetics</subject><subject>RNA, Messenger - metabolism</subject><subject>Transcription</subject><subject>Vaccination</subject><subject>Vaccines</subject><issn>0006-2979</issn><issn>1608-3040</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqNkc1u1DAUhS1ExUynPAAbNBIbNple24kdL6OqUKSqlVpYW459UzLKH3YyEjvegTfkSXA0A7RAEfLCP-c7x_fqEvKCwoZSnp7eAoBgSioqQALI7AlZxmOecEjhKVnOcjLrC3IcwjZeGSj-jCyYTFMlqFwS3t5cFUlpArr1-BG9GXAaaxu-fflauJ3pLIa16dx6QB8GtGO9w3BCjirTBHx-2Ffkw5vz92cXyeX123dnxWViM4AxyRlFwTOklCrKHZYgKoNpxpRlLhdIhROmctwY6lgsRoiqTHkpuGMWLAe-Iq_3uYPvP00YRt3WwWLTmA77KWiaQy5BZUr-DypBqpSlEX31G7rtJ9_FRjTLqVSQsVz9i4pZnCtQwH5Rd6ZBXXdVP3pj5691EWM4k1kmIrX5CxWXw7a2fYdVHd8fGOjeYH0fgsdKD75ujf-sKeh58vqPyUfPy0PBU9mi--n4MeoIsD0QotTdob_X0aOp3wFvWLMr</recordid><startdate>20160701</startdate><enddate>20160701</enddate><creator>Sergeeva, O. V.</creator><creator>Koteliansky, V. E.</creator><creator>Zatsepin, T. S.</creator><general>Pleiades Publishing</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7TM</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20160701</creationdate><title>mRNA-based therapeutics–Advances and perspectives</title><author>Sergeeva, O. V. ; Koteliansky, V. E. ; Zatsepin, T. S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c500t-821e635e111913deb06fae4529c2d86e16d6afd3aa1d261766fb43b63d2c0c303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Animals</topic><topic>Biochemistry</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Bioorganic Chemistry</topic><topic>Cancer immunotherapy</topic><topic>Clinical trials</topic><topic>Drug Carriers - chemistry</topic><topic>Humans</topic><topic>Immune response</topic><topic>Immune system</topic><topic>Immunity, Innate</topic><topic>Immunotherapy</topic><topic>Infectious diseases</topic><topic>Life Sciences</topic><topic>Lipids</topic><topic>Liposomes - chemistry</topic><topic>Microbiology</topic><topic>Nanoparticles</topic><topic>Nanoparticles - chemistry</topic><topic>Neoplasms - immunology</topic><topic>Neoplasms - therapy</topic><topic>Polymers</topic><topic>Review</topic><topic>RNA, Messenger - chemistry</topic><topic>RNA, Messenger - genetics</topic><topic>RNA, Messenger - metabolism</topic><topic>Transcription</topic><topic>Vaccination</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sergeeva, O. V.</creatorcontrib><creatorcontrib>Koteliansky, V. E.</creatorcontrib><creatorcontrib>Zatsepin, T. S.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Biochemistry (Moscow)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sergeeva, O. V.</au><au>Koteliansky, V. E.</au><au>Zatsepin, T. S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>mRNA-based therapeutics–Advances and perspectives</atitle><jtitle>Biochemistry (Moscow)</jtitle><stitle>Biochemistry Moscow</stitle><addtitle>Biochemistry (Mosc)</addtitle><date>2016-07-01</date><risdate>2016</risdate><volume>81</volume><issue>7</issue><spage>709</spage><epage>722</epage><pages>709-722</pages><issn>0006-2979</issn><eissn>1608-3040</eissn><abstract>In this review we discuss features of mRNA synthesis and modifications used to minimize immune response and prolong efficiency of the translation process in vivo . Considerable attention is given to the use of liposomes and nanoparticles containing lipids and polymers for the mRNA delivery. Finally we briefly discuss mRNAs which are currently in the clinical trials for cancer immunotherapy, vaccination against infectious diseases, and replacement therapy.</abstract><cop>Moscow</cop><pub>Pleiades Publishing</pub><pmid>27449617</pmid><doi>10.1134/S0006297916070075</doi><tpages>14</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-2979
ispartof Biochemistry (Moscow), 2016-07, Vol.81 (7), p.709-722
issn 0006-2979
1608-3040
language eng
recordid cdi_proquest_miscellaneous_1808709597
source MEDLINE; Springer Nature - Complete Springer Journals
subjects Animals
Biochemistry
Biomedical and Life Sciences
Biomedicine
Bioorganic Chemistry
Cancer immunotherapy
Clinical trials
Drug Carriers - chemistry
Humans
Immune response
Immune system
Immunity, Innate
Immunotherapy
Infectious diseases
Life Sciences
Lipids
Liposomes - chemistry
Microbiology
Nanoparticles
Nanoparticles - chemistry
Neoplasms - immunology
Neoplasms - therapy
Polymers
Review
RNA, Messenger - chemistry
RNA, Messenger - genetics
RNA, Messenger - metabolism
Transcription
Vaccination
Vaccines
title mRNA-based therapeutics–Advances and perspectives
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T05%3A07%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=mRNA-based%20therapeutics%E2%80%93Advances%20and%20perspectives&rft.jtitle=Biochemistry%20(Moscow)&rft.au=Sergeeva,%20O.%20V.&rft.date=2016-07-01&rft.volume=81&rft.issue=7&rft.spage=709&rft.epage=722&rft.pages=709-722&rft.issn=0006-2979&rft.eissn=1608-3040&rft_id=info:doi/10.1134/S0006297916070075&rft_dat=%3Cgale_proqu%3EA528327556%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1803390902&rft_id=info:pmid/27449617&rft_galeid=A528327556&rfr_iscdi=true